ACTIVE SUBSTANCE / INN

ISTRADEFYLLINE

Brand name(s): NOURIANZ, Nouryant
FDA LISTED
EMA LISTED
PRESCRIPTION
REFUSED
Parkinson Disease
NDA022075
ACTIVE SUBSTANCE
Istradefylline
REGULATORS
FDA · EMA
SPONSORS / MAH
Kyowa Kirin Holdings B.V., KYOWA KIRIN
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NOURIANZNDA022075KYOWA KIRINPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NouryantKyowa Kirin Holdings B.V.RefusedParkinson Disease

FULL INTELLIGENCE ON ISTRADEFYLLINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →